An official website of the United States government
Vaccination coverage estimates from the National Health Interview Survey: United States, 2008
by Jeannine S. Schiller, M.P.H., National Center for Health Statistics, Centers for Disease Control and Prevention; and Gary L. Euler, Dr.P.H., National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention
PDF Version (88 KB)
Although vaccinations are responsible for reducing morbidity and mortality from several diseases, vaccination uptake among certain population subgroups remains low, and national health objectives have not been met (1-3). Despite 2010 influenza and pneumococcal vaccination objectives of 90% for adults aged 65 years and over and 60% for younger high-risk adults, only 66% and 35% of these groups, respectively, received an influenza vaccination during the 2006-2007 vaccination period (primarily September-February) (1-2). Similarly, only 60% of adults aged 65 years and over have ever received a pneumococcal vaccination, and levels vary considerably by race/ethnicity (3). The National Health Interview Survey (NHIS) historically includes several questions on receipt of well-established vaccinations and recently added questions on newly licensed vaccines. This Health E-Stat provides information on vaccination coverage for influenza, pneumococcal disease, tetanus (including pertussis), shingles, hepatitis A, hepatitis B, and human papillomavirus (HPV) by selected characteristics (age, vaccination target group status, and race/ethnicity) in Tables 1 and 2. Findings about coverage of new vaccines are highlighted here.
The prevalence of tetanus vaccination during the past 10 years was over 60% for adults aged 19-49 years and 50-64 years, compared with 52% for older adults (Table 2). Among all age groups, non-Hispanic whites (19-49 years: 69%, 50-64 years: 66%, 65 years and over: 54%) were more likely than non-Hispanic blacks (19-49 years: 57%, 50-64 years: 52%, 65 years and over: 37%) and Hispanics (19-49 years: 51%, 50-64 years: 48%, 65 years and over: 48%) to have been vaccinated. Approximately half (52%) of adults aged 19-64 years who had received a tetanus shot since 2005, when Tdap (the pertussis-containing tetanus vaccine) was first available, were given this recommended vaccine. Rates were similar among the racial/ethnic groups examined (non-Hispanic whites: 50%, non-Hispanic blacks: 56%, Hispanics: 53%).
The rate of shingles vaccination-licensed in May 2006 for adults aged 60 years and over-was 7% for this age group (Table 2). Rates were higher for non-Hispanic whites (8%) than for non-Hispanic blacks (3%) and Hispanics (2%). Among adults aged 50-59 years, 3% had received the vaccination (results not shown). Low coverage may be related to the many barriers that exist for shingles vaccination for both physicians and patients, including high vaccine cost and substantial up-front out-of-pocket expense, complex methods for reimbursement, and a requirement for freezer storage (4-5).
A vaccine for HPV was licensed in 2006, and recommendations published by the Centers for Disease Control and Prevention in March 2007 included catch-up vaccination for females aged 13-26 years (6). Eleven percent of women aged 19-26 years received at least one HPV vaccination (Table 2), and 6% received three or more doses (results not shown). Levels were higher among non-Hispanic whites (13%) than among non-Hispanic blacks (7%) and Hispanics (6%). Among women aged 27-49 years, 0.8% had at least initiated the vaccination series (results not shown). Low rates of HPV vaccination exist despite reportedly high awareness of both the disease and the vaccine (approximately 80%) (7). This study (7) also found that women of higher socioeconomic status were more likely to be vaccinated. Estimates of HPV vaccination were calculated for a period not long (10 to 21 months) after the publication of the recommendations. Low coverage may be related to a variety of factors including high cost of the vaccine and because the primary target group for HPV vaccine is females aged 11-12 years old.
The NHIS – a nationally representative survey of the civilian noninstitutionalized household population of the United States conducted throughout the year from January through December – uses in-person interviews to collect information on health and health care for all eligible members of the sampled households. Information on adult vaccinations is self-reported by one randomly sampled adult within a family, except in rare cases when the selected adult is physically or mentally incapable of responding. Information on child vaccinations is provided by a knowledgeable adult household member. Vaccination questions are provided in the table footnotes. Analyses were based on data for 21,781 adults and 8,815 children. Estimates were calculated using SUDAAN software (8), to account for the complex sample design of the NHIS, and were weighted to reflect the U.S. civilian noninstitutionalized population. Estimates shown have less than or equal to 30% relative standard error. Estimates were compared using two-tailed significance tests at the 0.05 level, with no adjustment for multiple comparisons. Visit the NHIS website for more information.
References
- U.S. Department of Health and Human Services. Healthy People 2010. 2nd ed. With Understanding and Improving Health and Objectives for Improving Health. 2 vols. Washington, DC: U.S. Government Printing Office. 2000.
- CDC. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR 57(RR-07):1-60. 2008.
- Heyman KM, Barnes PM, Schiller JS. Early release of selected estimates based on data from the 2008 National Health Interview Survey. National Center for Health Statistics. 2009. Available from the NHIS website .
- Lu PJ, Euler GL, Jumaan AO, Harpaz R. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: Uptake of the first new vaccine to target seniors. Vaccine 27(6):882-7. 2009.
- Hurley LP, Lindley MC, Harpaz R, Stokely S, Daley M, Crane LA, et al. Herpes zoster vaccine: What is interfering with uptake? [PPT – 1.5 MB] Presented at: 43rd National Immunization Conference; 2009 March 30-April 2, Dallas, TX.
- CDC. Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 56(RR-02):1-24. 2007.
- Jain N, Euler GL, Shefer A, Lu PJ, Yankey D, Markowitz L. Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007. Prev Med 48(5):426-31. 2009.
- Research Triangle Institute. SUDAAN [computer software]. Release 10.0.0. Research Triangle Park, NC: Research Triangle Institute. 2008.
Tables
Table 1. Percentage of persons aged 6 months and over who had received an influenza vaccination during September 2007 through February 2008 (2007-2008 influenza season), by age group, high-risk status, health care personnel status, and race/ethnicity: United States, 2008
| Age group, high-risk1 (HR) status, health care personnel2 status, and race/ethnicity3 |
Sample size | Percent (95% CI) |
|---|---|---|
| 6 months-18 years4 | 4,091 | 26.5 (24.81-28.19) |
| 6-23 months5 | 270 | 49.2 (41.77-56.63) |
| 2-4 years | 638 | 40.3 (35.34-45.26) |
| 5-18 years, HR | 262 | 38.0 (30.67-45.33) |
| 5-18 years, non-HR | 2,915 | 20.5 (18.70-22.30) |
| 5-12 years, non-HR | 1,568 | 25.2 (22.59-27.81) |
| 13-18 years, non-HR | 1,347 | 14.6 (12.35-16.85) |
| 19-49 years, HR, total | 1,016 | 30.0 (26.47-33.53) |
| 19-49 years, HR, not Hispanic or Latino, single race, white | 624 | 30.3 (25.91-34.69) |
| 19-49 years, HR, not Hispanic or Latino, single race, black | 185 | 33.4 (24.68-42.12) |
| 19-49 years, HR, Hispanic or Latino | 172 | 23.7 (16.10-31.30) |
| 19-49 years, non-HR, total | 5,984 | 17.4 (16.26-18.54) |
| 19-49 years, non-HR, not Hispanic or Latino, single race, white | 3,137 | 19.3 (17.77-20.83) |
| 19-49 years, non-HR, not Hispanic or Latino, single race, black | 986 | 12.9 (10.47-15.33) |
| 19-49 years, non-HR, Hispanic or Latino | 1,379 | 13.0 (10.80-15.20) |
| 50-64 years, total | 3,155 | 38.7 (36.70-40.70) |
| 50-64 years, not Hispanic or Latino, single race, white | 2,099 | 40.9 (38.57-43.23) |
| 50-64 years, not Hispanic or Latino, single race, black | 493 | 32.1 (26.93-37.27) |
| 50-64 years, Hispanic or Latino | 399 | 30.0 (24.79-35.21) |
| 50-64 years, HR, total | 988 | 48.8 (45.06-52.54) |
| 50-64 years, HR, not Hispanic or Latino, single race, white | 629 | 49.3 (44.73-53.87) |
| 50-64 years, HR, not Hispanic or Latino, single race, black | 173 | 45.4 (36.05-54.75) |
| 50-64 years, HR, Hispanic or Latino | 143 | 47.5 (37.66-57.34) |
| 50-64 years, non-HR, total | 2,158 | 34.4 (32.05-36.75) |
| 50-64 years, non-HR, not Hispanic or Latino, single race, white | 1,463 | 37.4 (34.62-40.18) |
| 50-64 years, non-HR, not Hispanic or Latino, single race, black | 320 | 25.8 (20.02-31.58) |
| 50-64 years, non-HR, Hispanic or Latino | 256 | 21.9 (15.88-27.92) |
| 19-64 years, health care personnel, total | 945 | 45.4 (41.95-48.85) |
| 19-64 years, health care personnel, not Hispanic or Latino, single race, white | 543 | 49.6 (45.41-53.79) |
| 19-64 years, health care personnel, not Hispanic or Latino, single race, black | 211 | 30.4 (22.68-38.12) |
| 19-64 years, health care personnel, Hispanic or Latino | 136 | 40.0 (29.65-50.35) |
| 65 years and over, total | 2,595 | 66.6 (64.58-68.62) |
| 65 years and over, not Hispanic or Latino, single race, white | 1,835 | 69.4 (67.13-71.67) |
| 65 years and over, not Hispanic or Latino, single race, black | 365 | 53.2 (47.57-58.83) |
| 65 years and over, Hispanic or Latino | 262 | 51.2 (44.09-58.31) |
1 Children under age 18 years were considered at high risk for influenza-related complications if they had ever been told by a doctor or other health professional that they had diabetes, cystic fibrosis, sickle cell anemia, congenital heart disease, other heart disease, or neuromuscular conditions (seizures, cerebral palsy, and muscular dystrophy); or had an asthma episode or attack during the preceding 12 months. Adults were considered at high risk for influenza-related complications if they had ever been told by a doctor or other health professional that they had diabetes, emphysema, coronary heart disease, angina, heart attack, or other heart condition; had a diagnosis of cancer during the previous 12 months (excluding nonmelanoma skin cancer); had ever been told by a doctor or other health professional that they had lymphoma, leukemia, or blood cancer; had been told by a doctor or other health professional that they had chronic bronchitis or weak or failing kidneys during the preceding 12 months; or had an asthma episode or attack during the preceding 12 months.
2 Adults were classified as health care personnel if they were currently employed in a health care occupation or in a health care industry setting, on the basis of standard occupation and industry categories.
3 Persons who indicated a single race other than the race groups shown are included in the total but are not shown separately due to small sample sizes. Therefore, the frequencies for totals will be greater than the sum of the frequencies for the specific groups shown separately. Persons of Hispanic or Latino origin may be of any race or combination of races. The tables in this report use the complete current (1997) Office of Management and Budget race and Hispanic origin terms, and the text uses shorter versions of these terms, for conciseness.
4 Starting with the 2008-2009 influenza season, the Advisory Committee on Immunization Practices (ACIP) expanded its child recommendation for annual influenza vaccination to include all children aged 6 months through 18 years. Prior to the 2008-2009 influenza season, ACIP’s child annual influenza vaccination recommendation was limited to all children aged 6 months through 4 years and children aged 5 through 18 years at high risk for serious complications from influenza. Starting with the 2007-2008 influenza season, all children aged 6 months through 8 years who have no prior influenza vaccination should receive two doses of vaccine (4 or more weeks apart) the first year they are vaccinated (and if not the first year, the second year). For the 2008-2009 season this included most children aged 6-23 months, as well as those aged 2 through 18 years previously unvaccinated or in their second year following a one-dose first year.
5 The National Immunization Survey (NIS) is the usual source of influenza vaccination estimates for children aged 6-23 months, including estimates of the proportion fully vaccinated with two doses as indicated. Estimates based on the NIS will be available in fall 2009.
NOTES: CI is confidence interval. Respondents were asked in separate questions if they had received a flu shot during the past 12 months and if they had received a flu vaccine sprayed in their nose during the past 12 months. If so, month and year of most recent shot/vaccine were asked for each question. Estimates were based on interviews conducted during March through August and included vaccinations received from September 2007 through February 2008. Inclusion and development of the vaccination questions on the National Health Interview Survey were supported, in part, by the National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention.
DATA SOURCE: CDCNCHS, National Health Interview Survey, 2008. Estimates are based on household interviews of a sample of the civilian noninstitutionalized population.
Table 2a. Percentage of adults aged 19 years and over who had ever received a pneumococcal vaccination,4 by age group, high-risk status, and race/ethnicity: United States, 2008
| Age group, high-risk1 (HR) status, and race/ethnicity3 | Sample size | Percent (95% CI) |
|---|---|---|
| 19-64 years, HR, total | 3,044 | 24.9 (23.08-26.72) |
| 19-64 years, HR, not Hispanic or Latino, single race, white | 1,948 | 26.5 (24.25-28.75) |
| 19-64 years, HR, not Hispanic or Latino, single race, black | 514 | 22.6 (17.70-27.50) |
| 19-64 years, HR, Hispanic or Latino | 447 | 15.8 (11.68-19.92) |
| 65 years and over, total | 4,265 | 60.0 (58.29-61.71) |
| 65 years and over, not Hispanic or Latino, single race, white | 3,052 | 64.3 (62.38-66.22) |
| 65 years and over, not Hispanic or Latino, single race, black | 571 | 44.6 (39.27-49.93) |
| 65 years and over, Hispanic or Latino | 424 | 36.4 (31.15-41.65) |
See footnotes at end of Table 2g.
Table 2b 19 years over
Table 2b. Percentage of adults aged 19 years and over who had received a tetanus vaccination in the past 10 years,5 by age group and race/ethnicity: United States, 2008
| Age group and race/ethnicity3 | Sample size | Percent (95% CI) |
|---|---|---|
| 19-49 years, total | 11,154 | 63.6 (62.38-64.82) |
| 19-49 years, not Hispanic or Latino, single race, white | 6,085 | 69.2 (67.69-70.71) |
| 19-49 years, not Hispanic or Latino, single race, black | 1,818 | 57.1 (54.16-60.04) |
| 19-49 years, Hispanic or Latino | 2,402 | 51.1 (48.47-53.73) |
| 50-64 years, total | 5,003 | 62.4 (60.81-63.99) |
| 50-64 years, not Hispanic or Latino, single race, white | 3,367 | 66.0 (64.20-67.80) |
| 50-64 years, not Hispanic or Latino, single race, black | 785 | 52.0 (47.61-56.39) |
| 50-64 years, Hispanic or Latino | 593 | 48.1 (42.83-53.37) |
| 65 years and over, total | 4,109 | 51.9 (49.96-53.84) |
| 65 years and over, not Hispanic or Latino, single race, white | 2,935 | 54.4 (52.20-56.60) |
| 65 years and over, not Hispanic or Latino, single race, black | 546 | 37.0 (32.20-41.80) |
| 65 years and over, Hispanic or Latino | 418 | 47.5 (41.01-53.99) |
See footnotes at end of Table 2g.
Table 2c 19-64 years
Table 2c. Percentage of adults aged 19-64 years who had received a tetanus vaccination including pertussis vaccine since 2005,6 by race/ethnicity: United States, 2008
| Race/ethnicity3 | Sample size | Percent (95% CI) |
|---|---|---|
| 19-64 years, total | 1,312 | 51.5 (48.13-54.87) |
| 19-64 years, not Hispanic or Latino, single race, white | 899 | 50.1 (46.12-54.08) |
| 19-64 years, not Hispanic or Latino, single race, black | 197 | 56.2 (47.65-64.75) |
| 19-64 years, Hispanic or Latino | 158 | 52.9 (43.14-62.66) |
See footnotes at end of Table 2g.
Table 2d 60 years over
Table 2d. Percentage of adults aged 60 years and over who had ever received the shingles vaccination,7 by race/ethnicity: United States, 2008
| Race/ethnicity3 | Sample size | Percent (95% CI) |
|---|---|---|
| 60 years and over, total | 5,751 | 6.7 (5.90-7.50) |
| 60 years and over, not Hispanic or Latino, single race, white | 4,134 | 7.6 (6.64-8.56) |
| 60 years and over, not Hispanic or Latino, single race, black | 766 | 2.5 (1.17-3.83) |
| 60 years and over, Hispanic or Latino | 562 | 2.1 (0.90-3.30) |
See footnotes at end of Table 2g.
Table 2e 19-49 years
Table 2e. Percentage of adults aged 19-49 years who had ever received the hepatitis A vaccination (at least 2 doses),8 by high-risk status and race/ethnicity: United States, 2008
| High-risk1 (HR) status and race/ethnicity3 | Sample size | Percent (95% CI) |
|---|---|---|
| 19-49 years, total | 10,284 | 8.8 (8.02-9.58) |
| 19-49 years, not Hispanic or Latino, single race, white | 5,656 | 9.3 (8.30-10.30) |
| 19-49 years, not Hispanic or Latino, single race, black | 1,680 | 7.6 (6.01-9.19) |
| 19-49 years, Hispanic or Latino | 2,203 | 7.5 (5.93-9.07) |
| 19-49 years, had traveled outside the United States to countries other than Europe, Japan, Australia, New Zealand, or Canada since 1995 | 3,376 | 14.4 (12.91-15.89) |
| 19-49 years, had not traveled outside the United States to countries other than Europe, Japan, Australia, New Zealand, or Canada since 1995 | 6,887 | 6.1 (5.26-6.94) |
See footnotes at end of Table 2g.
Table 2f 19-49 years
Table 2f. Percentage of adults aged 19-49 years who had ever received the hepatitis B vaccination (at least 3 doses),9 by high-risk status, health care personnel status, and race/ethnicity: United States, 2008
| High-risk1 (HR) status, health care personnel2 status, and race/ethnicity3 | Sample size | Percent (95% CI) |
|---|---|---|
| 19-49 years, HR, total | 400 | 31.6 (25.97-37.23) |
| 19-49 years, HR, not Hispanic or Latino, single race, white | 245 | 33.1 (25.99-40.21) |
| 19-49 years, HR, not Hispanic or Latino, single race, black | 64 | 22.9 (10.89-34.91) |
| 19-49 years, HR, Hispanic or Latino | 72 | 25.6 (13.02-38.18) |
| 19-49 years, non-HR, total | 10,030 | 33.8 (32.39-35.21) |
| 19-49 years, non-HR, not Hispanic or Latino, single race, white | 5,483 | 36.7 (34.98-38.42) |
| 19-49 years, non-HR, not Hispanic or Latino, single race, black | 1,655 | 31.8 (28.86-34.74) |
| 19-49 years, non-HR, Hispanic or Latino | 2,132 | 24.8 (22.17-27.43) |
| 19-49 years, health care personnel, total | 1,078 | 69.3 (65.99-72.61) |
| 19-49 years, health care personnel, not Hispanic or Latino, single race, white | 601 | 74.0 (69.86-78.14) |
| 19-49 years, health care personnel, not Hispanic or Latino, single race, black | 239 | 56.9 (49.61-64.19) |
| 19-49 years, health care personnel, Hispanic or Latino | 166 | 62.1 (53.32-70.88) |
See footnotes at end of Table 2g.
Table 2g 19-26 years
Table 2g. Percentage of adults aged 19-26 years who had ever received the human papillomavirus (HPV) vaccination (at least 1 dose),10 by race/ethnicity: United States, 2008
| Race/ethnicity3 | Sample size | Percent (95% CI) |
|---|---|---|
| 19-26 years, total | 1,381 | 10.5 (8.48-12.52) |
| 19-26 years, not Hispanic or Latino, single race, white | 691 | 13.3 (10.38-16.22) |
| 19-26 years, not Hispanic or Latino, single race, black | 286 | 6.8 (3.12-10.48) |
| 19-26 years, Hispanic or Latino | 296 | 6.4 (3.17-9.63) |
Adults were considered at high risk for pneumococcal disease if they had ever been told by a doctor or other health professional that they had diabetes, emphysema, coronary heart disease, angina, heart attack, or other heart condition; had a diagnosis of cancer during the previous 12 months (excluding nonmelanoma skin cancer); had ever been told by a doctor or other health professional that they had lymphoma, leukemia, or blood cancer; or had been told by a doctor or other health professional that they had chronic bronchitis or weak or failing kidneys during the preceding 12 months. Adults were considered at high risk for hepatitis B if they had hemophilia and had received clotting factor concentrations, were a man who had sex with other men, had taken street drugs by needle, had traded sex for money or drugs, had tested positive for HIV, or had sex with someone who would meet any of the previous criteria.
2 Adults were classified as health care personnel if they were currently employed in a health care occupation or in a health care industry setting, on the basis of standard occupation and industry categories.
3 Persons who indicated a single race other than the race groups shown are included in the total but are not shown separately due to small sample sizes. Therefore, the frequencies for totals will be greater than the sum of the frequencies for the specific groups shown separately. Persons of Hispanic or Latino origin may be of any race or combination of races. The tables in this report use the complete current (1997) Office of Management and Budget race and Hispanic origin terms, and the text uses shorter versions of these terms, for conciseness.
4 Respondents were asked if they had ever had a pneumonia shot.
5 Respondents were asked if they had received a tetanus shot in the past 10 years.
6 Respondents who had received a tetanus shot in the past 10 years were asked if their most recent shot was given in 2005 or later. Respondents who had received a tetanus shot since 2005 were asked if they were told that their most recent tetanus shot included the pertussis or whooping cough vaccine.
7 Respondents were asked if they had ever received a shingles vaccine.
8 Respondents were asked if they had ever received the hepatitis A vaccine, and if yes, were asked how many shots were received.
9 Respondents were asked if they had ever received the hepatitis B vaccine, and if yes, if they had received at least three doses or less than three doses.
10 Respondents were asked if they had ever received the HPV shot or cervical cancer vaccine.
NOTES: CI is confidence interval. Inclusion and development of the vaccination questions on the National Health Interview Survey were supported, in part, by the National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention. Inclusion and development of the HPV questions on the NHIS were also supported, in part, by the National Cancer Institute, National Institutes of Health.
DATA SOURCE: CDCNCHS, National Health Interview Survey, 2008. Estimates are based on household interviews of a sample of the civilian noninstitutionalized population.